Effects of the Galanin Receptor Antagonist M40 on Cardiac Function and Remodeling in Rats with Heart Failure.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cardiovascular Therapeutics

• Publication date

  2015-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1755-5922.12144PMID 26177027
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial.

  2014cited by this paper
• Donepezil markedly improves long-term survival in rats with chronic heart failure after extensive myocardial infarction.

  2013cited by this paper
• The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: Implications for neural control of cardiac excitability

  2012cited by this paper
• Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms.

  2011cited by this paper
• Sympathetic–parasympathetic interaction in health and disease: abnormalities and relevance in heart failure

  2011cited by this paper
• High-intensity exercise training in mice with cardiomyocyte-specific disruption of Serca2.

  2010cited by this paper
• Galanin and the neuroendocrine axes.

  2010cited by this paper
• Exercise training before cardiac-specific Serca2 disruption attenuates the decline in cardiac function in mice.

  2010cited by this paper
• Sympathetic Nervous System Modulation of Inflammation and Remodeling in the Hypertensive Heart

  2010cited by this paper
• Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.

  2010cited by this paper
• Neurochemical modulation of central cardiovascular control: the integrative role of galanin.

  2010cited by this paper
• Autonomic neurotransmission: 60 years since sir Henry Dale.

  2009cited by this paper
• Galanin – 25 years with a multitalented neuropeptide

  2008cited by this paper
• Post-infarct cardiac sympathetic hyperactivity regulates galanin expression.

  2008cited by this paper
• Physiology and immunology of the cholinergic antiinflammatory pathway.

  2007cited by this paper
• Altered cardiac myocyte Ca regulation in heart failure.

  2006cited by this paper
• Galanin modulates cholinergic neurotransmission in the heart.

  2005cited by this paper
• Myocardial infarction stimulates galanin expression in cardiac sympathetic neurons.

  2005cited by this paper
• Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse

  2003cited by this paper
• Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

  2000cited by this paper
• Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.

  2000cited by this paper
• Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

  2000cited by this paper
• The cellular and physiologic effects of beta blockers in heart failure.

  1999cited by this paper
• The cellular and physiologic effects of beta blockers in heart failure.

  1999cited by this paper
• Echocardiographic assessment of cardiac function in conscious and anesthetized mice.

  1999cited by this paper
• Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.

  1998cited by this paper
• Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure.

  1993cited by this paper
• Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte

  1992cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

  1990cited by this paper
• Galanin- and neuropeptide Y-like immunoreactivities coexist in paravertebral sympathetic neurones of the cat.

  1987cited by this paper
• Galanin — a novel biologically active peptide from porcine intestine

  1983cited by this paper

• Galanin Receptors: G Protein-Dependent Signaling and Beyond.

  2026cites this paper
• Effects of celastrol on the heart and liver galaninergic system expression in a mouse model of Western-type diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis

  2025cites this paper
• Modern ideas about the role of the galaninergic system in the pathogenesis of heart failure and myocardial remodeling

  2023cites this paper
• Alleviation of Limosilactobacillus reuteri in polycystic ovary syndrome protects against circadian dysrhythmia-induced dyslipidemia via capric acid and GALR1 signaling

  2023cites this paper
• The mechanism of Renshen-Fuzi herb pair for treating heart failure—Integrating a cardiovascular pharmacological assessment with serum metabolomics

  2022cites this paper
• Stress-related dysautonomias and neurocardiology-based treatment approaches.

  2022cites this paper
• Signaling and function of cardiac autonomic nervous system receptors: Insights from the GPCR signalling universe

  2021cites this paper
• Alarin moderated myocardial hypertrophy via inhibiting cyclic adenosine monophosphate/protein kinase A signaling pathway to attenuate autophagy.

  2021cites this paper
• Regulatory Influence of Galanin and GALR1/GALR2 Receptors on Inflamed Uterus Contractility in Pigs

  2021cites this paper
• Galanin Peptides Alleviate Myocardial Ischemia/Reperfusion Injury by Reducing Reactive Oxygen Species Formation

  2021cites this paper
• Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers

  2020cites this paper
• Co-ordinated targeting of galanin receptors on cholangiocytes and hepatic stellate cells ameliorates liver fibrosis in Mdr2-knockout mice.

  2020cites this paper
• Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments

  2020cites this paper
• Galanin/GalR1-3 system: A promising therapeutic target for myocardial ischemia/reperfusion injury.

  2019cites this paper
• Galanin and its N‐terminal fragments reduce acute myocardial infarction in rats

  2019cites this paper
• Role of sympathetic cotransmitter galanin on autonomic balance in heart failure: an active player or a bystander?

  2017cites this paper
• Cardioprotective properties of N-terminal galanin fragment (2-15) in experimental ischemia/reperfusion injury

  2017cites this paper
• Myocardial protection from ischemia/reperfusion injury by exogenous galanin fragment

  2017influential citation
• The role of neuropeptides in adverse myocardial remodeling and heart failure

  2017cites this paper
• Tanshinon II A attenuates diabetic cardiomyopathy by down-regulation of mTOR / P 70 S 6 K signaling pathway

  2016influential citation
• Low-Level Vagus Nerve Stimulation Reverses Cardiac Dysfunction and Subcellular Calcium Handling in Rats With Post-Myocardial Infarction Heart Failure.

  2016cites this paper